chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Achiness; Couldn't get out of bed; Lost strength in legs; Leg weakness; White count was up a little bit; This spontaneous case was reported by a physician and describes the occurrence of MYALGIA (Achiness), VACCINATION COMPLICATION (Couldn't get out of bed), LIMB DISCOMFORT (Lost strength in legs), MUSCULAR WEAKNESS (Leg weakness) and WHITE BLOOD CELL COUNT INCREASED (White count was up a little bit) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Stroke. Concurrent medical conditions included Cancer (chemotheraphy for cancer).   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced MYALGIA (Achiness), VACCINATION COMPLICATION (Couldn't get out of bed), LIMB DISCOMFORT (Lost strength in legs), MUSCULAR WEAKNESS (Leg weakness) and WHITE BLOOD CELL COUNT INCREASED (White count was up a little bit). At the time of the report, MYALGIA (Achiness), VACCINATION COMPLICATION (Couldn't get out of bed), LIMB DISCOMFORT (Lost strength in legs), MUSCULAR WEAKNESS (Leg weakness) and WHITE BLOOD CELL COUNT INCREASED (White count was up a little bit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
I woke up the next day after my flu vaccine, I had super throat. I had some bronchial congestion and runny nose. I felt very tired and listless. I eventually had a pain in my back - left shoulder under the blade. I had the pain for a week to 10 days.  When I laid down, I couldn't sleep at night because it hurt.  Last week, I had a CT scan for that to check for blood clots. Zithromax - for the bronchial congestion. It helped for that. I have a history of having bronchial congestion, so I have to get something for that always. I do still have some croakiness in my throat. I do live on a busy street with lots of traffic so I may have it from that. My doctor visit was telemed - via telephone. I had flu vaccine on the 26th of October. 2021. I had the flu vaccine in my left arm.
Pt. developed pruritic progressive dermatitis approximately 6 to 12 hrs. after vaccine administered. She was treated with SOLU MEDROL 40mg x1 dose, VISTARIL 25mg as needed for itching.
Bells palsy on same side as vaccine; A spontaneous report was received from a consumer concerning 69-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced facial palsy.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.    On 13 Jan 2021,the patient received his first of the two planned vaccine doses of mRNA-1273 (Batch number: 039K20A).    On 10 Feb 2021, approximately 28 days after the first vaccine dose, prior to the onset of the symptoms, the patient received his second of the two planned vaccine doses of mRNA-1273 (Batch number: 028L20A), intramuscularly, in the left arm, for prophylaxis of COVID-19 infection.   On an unknown date, after 2.5 weeks of the second dose of vaccination, the patient experienced bell's palsy on the same side he received  the vaccine and was reported as ongoing at the time of report.    Treatment for the event included steroid, antiviral and eyedrops.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events was not applicable.  The outcome of the events, facial paralysis and cerebrovascular accident, were considered not resolved at the time of report.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
This case was reported by a nurse via call center representative and described the occurrence of injection site tenderness in a adult patient who received FLULAVAL QUADRIVALENT 2018-2019 season) (batch number EF4Z9, expiry date 22nd June 2019) for prophylaxis. On 1st October 2018, the patient received FLULAVAL QUADRIVALENT 2018-2019 season (subcutaneous) .5 ml. On 1st October 2018, unknown after receiving FLULAVAL QUADRIVALENT 2018-2019 season, the patient experienced intramuscular formulation administered by other route. On 2nd October 2018, the patient experienced injection site tenderness, injection site swelling and injection site erythema. On an unknown date, the outcome of the injection site tenderness, injection site swelling and injection site erythema were not recovered/not resolved and the outcome of the intramuscular formulation administered by other route was unknown. It was unknown if the reporter considered the injection site tenderness, injection site swelling and injection site erythema to be related to FLULAVAL QUADRIVALENT 2018-2019 season. Additional details were provided as follows: The age at vaccination was not reported. The healthcare professional (HCP) stated that her co-worker was inadvertently administered FLULAVAL QUADRIVALENT 2018-2019 season subcutaneously instead of the indicated intramuscular route, which led to inappropriate route of vaccination. The HCP stated that the patient had redness, swelling, and tenderness at the injection site on the date of reporting, one day later. The HCP did not provide the patient information for this adverse event but did provide the lot number and expiry date for the adverse. This case is 1 of 15 cases, reported by the same reporter.
Information has been received from a physician concerning a 20 year old female with no medical history or allergies who within the last 3 months date was vaccinated with a dose of Gardasil. There was no concomitant medication. "Within the last week" it was reported that the patient had a positive pap smear test after receiving the first doses of the vaccine. The vaccinations were believed to be administered within the last 3 months. Unspecified medical attention was sought. At the time of this report, the patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
Phone call 8/29/04-developed red, hard area left deltoid region. Itching. Advised ice, Advil, Cortaid, Benadryl prn.
swelling, red, hard knot size of fist at injection site, chills, fever, headache, muscle cramps all lasting about 36 hours. patient recovered at 36 hours no additional problems.
Patient reports arm pain, stiffness, burning and hot to the touch starting the evening of adminstration and continuing into the following day.
No addittional adverse effects reported; MMR II that underwent temperature excursions was administered; This spontaneous report was received from an unspecified reporter referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, drug allergies/reactions or concomitant medications was not provided.  On 18-OCT-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneous injection, (valid lot #T033814, expiration date: 05-OCT-2022), administered for prophylaxis (strength, vaccination scheme frequency, anatomical location, and route of administration were not provided). The administered dose of the vaccine experienced a temperature excursion of 12.4 degrees Celsius for 53 minutes; 9.6 degrees Celsius for 34 minutes; 9.5 degrees Celsius for 23 minutes; and 8.5 degrees Celsius for 9 minutes. There was no adverse effect reported.; Sender's Comments:  US-009507513-2112USA007442: US-009507513-2112USA006870: US-009507513-2112USA007443:
Isolated urticaria, starting the next morning.  No vomiting, respiratory, edema symptoms.  Was irritable during the night but hives noted the next morning.  Swelling of the right thigh (approx 2.5 cm in diameter > left thigh), NO redness or warmth.
Pt vaccinated with TD c/o erythema & tightness at injection site 3 days after injection.
pt recv vax;seen in hlth dept; rash, conjunctivitis; fever 101.9;
Influenza like illness. A mother reported that her child received the 1st Prevnar on 3/27/01 and within 1 hr developed flu-like symptoms described as fever between 102F and 103F, stuffy nose, green drainage, nausea, earache, sore throat and coughing. The child's mother, father, and 2 year old sibling(who did not receive Prevnar) also developed these symptoms within 1 hr following the 10 month old's IZ. This is 1 of 2 reports from this family following the 10 month old's receipt of Prevnar.
Received MMR on 10/18/13 along with DTaP, Hib and Flu. Mother states since then has been "absolutely miserable wants to sleep". Fever up to 105 (rectal) x3 days, starting 10-26-13. Had loose stools. Hive like rash on 10/26/13 on arms, legs, back and stomach; tried to scratch it. Decreased appetite x6 days. Acetaminophen with benefit.
Two days following second dose of Moderna, patient began having symptoms of CVA in the late evening.  ER visit the following morning. Diagnosed wtih CVA.
Gave vaccination, child's leg had a reaction that evening. Went to ER and was hospitalized for two days.  2/2/09 MR received for DOS 12/9-11/2008 with D/C DX:  L thigh cellulitis. Pt presented with 1 day hx of swelling and erythema of the L thigh following vaccines given on 12/8/08.  Swelling and redness noted below the knee. Leg is tender and pt favoring when walking.  Tx with abx and Benadryl with resolution.
First was soreness and swelling on the arm, then overnight developed into fever, ache and headaches. That lasted all day after the shot, also felt bloated and nauseous, a bit of stomach ache. Fever stopped after a day.
The PENTACEL was incorrectly mixed prior to administration. Two vials of diluent were combined and administered. The vial with the powder Hib was not used.
Started losing vision in left eye.  Was diagnosed with bilateral posterior uveitis on 9/11/2017.  Had many tests and diagnosis is presumed occular sarcoidosis.  Took several months of prednisone and then was changed to 2000mg Cellcept, which is still going as of today. 7/3/3019. Sees a rheumatologist and retina specialist every four months.  Next visits are in August.  Vision will not be restored.
patient reports developing a migraine headache that has been refractory to treatment for months, now complicated by medication overuse.  she has a history of migraines but hadn't had any problems with migraines for years.
Patient received the H1N1 mist on 10/30 within 24hrs her temp was 103. She was vomiting had a severe headache a chest pain. Her chest pain and head pain were so severe that she returned to the DR with in 3 days and again on the 4th day. She has missed over 1 1/2 wks of school. Was taken to ER on 11/12/2009 and back to DR on 11/16 & 11/18. She now is on meds and has costochondritis & diffuse myositis & constant headache & chest pain. My daughter has now been to the ER twice 11/12 & 11/29 seen an infectious disease Dr. and a neurologist. We have gone to 8 Dr visits so far she has had several blood tests, CT scan & now needs an MRI & more xrays. This has cost us thousands of dollars. My daughter continues to have severe head pain & chest pain since receiving the H1N1 flu mist on Oct 30th. She was never sick like this before the immunization was given.
Post vax, the pt developed hives on neck, chest, and arms. Approximately 7 rashy-hives in large patches over arms and lower back and chest. He also had hoarse voice.
This case was reported by a other health professional via sales rep and described the occurrence of shoulder pain in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, several weeks after receiving SHINGRIX, the patient experienced shoulder pain, neck pain and bursitis. On an unknown date, the outcome of the shoulder pain, neck pain and bursitis were unknown. It was unknown if the reporter considered the shoulder pain, neck pain and bursitis to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced severe shoulder pain up into the neck weeks after vaccination. The patient had bursitis feeling, enough to where patient was unable to sleep on that side.
8/19/2022 presented to ER with cough and increased weakness per family since patient has dementia. Tested Covid + 8/19/2022.
After a few hours of administration of vaccine, felt soreness of arm at injection site.  Also, felt tired.  About less than 24 hours later, (next day around 11 am) felt fatigued and had similar symptoms to when experienced covid-19 in October 2020.  24 hours later, fatigue wore off but soreness of arm remained and lymph nodes in underarm were swollen.  Soreness of arm and swollen arm pit remain until today (01/19/2021.)
Dizziness, Headache, Started with dizziness, then mid day with headache and weakness and head congestion; recommendation for OTC Tylenol Narrative:
12 year old accidently given Moderna vaxccine, not approved for age at this time, instead of Pfizer, father notified will get Pfizer in  28 days to fiish off series
Patient received 0.3mL  second dose of Pfizer COVID-19 vaccine. Lot number above.   11:55 immunization 12:00 patient states she feels "shaky". take to observation room where rescue meds available.  12:05 patient reports lightheadedness. Given 8 oz of water which she took orally.  12:10 patient feels nauseous.  BP 122/72  P 92 O2 100% Resp 18 12:15 patient reports she is more lightheaded/dizzy. She is reclined on bed and uses her phone to text her significant other.  12:20 patient reports symptoms are improving. Given another 8 oz of water which she took orally. Reports she did eat breakfast this day, but not lunch. No meds taken.  12:25 patient reports she is feeling better and sits up. BP 110/80 12:30 patient taken to lounge chair and on her phone.  12:40 patient reports all symptoms have resolved and she would like to leave. She is escorted to her car by RN and advised to call PCP or go to ER with any new or returning symptoms. Voices understanding.
Pt noticed itching, swelling 7 hrs after injection. Used ice. Next AM had 3x 4 inch slightly red, swelling at injection site. Seems to be improving. Doesn't drive refused appointment.
Pt received AFLURIA on 9/24/11 (Sat). Came into pharmacy Mon 9/26/11 stating that his arm was tingling & he was developing a rash & was going to ER.
pt presented to Health Department 5 days after vaccine was given with a red swollen area on her right arm below the deltoid muscle. Area measured 5x2in. Area was warm to touch. patient when to her PCP and was diagnosed with cellulitis and was placed on antibiotics.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown demographics. No concurrent conditions or medical history were provided. On an unknown date, those patients were vaccinated with doses of improperly stored PROQUAD (Merck) injection (lot # L023111, expiry date: 24-DEC-2016; strength, dose, site and route of administration were unspecified). No concomitant medications were reported. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Mom called stating child broke out in bumps on trunk, back, arms, legs and 1 foot.  Complained of itching, denied any drainage, had low grade fever up to 100 F.  Mom stated bumps resolved after 4 days.  Did not go to MD's office.  Mom called clinic on 4-17-08.
Information has been received from a health professional concerning a 21 year old white female with no medical history or allergies, who on 19-MAR-2007 was vaccinated intramuscularly in the right deltoid with a first dose of Gardasil (Lot # 655503/0012U). Concomitant therapy included YAZ and ALLEGRA. Subsequently, the patient experienced syncope. The patient had no illness at the time of the vaccination. It was noted that the patient had not eaten that morning. The patient had recovered on 19-MAR-2007. Additional information has been requested.
8/10/20 1910 - Diffuse macular erythema in large patches
Initial report received from another company on 8/25/05. This case was reported to the other company by a consumer and the events have not been medically confirmed by a physician or other health care professional. A 58 year old female patient with a medical history of breast cancer, had received an injection of YF-VAX, lot number unknown, on 4/22/05. The route and site of administration were unknown. That same day, she received a first dose of Havrix, lot number AHAVB043BA, administered in the right arm. On an unspecified date in July 2005, three months post vaccination, the patient experienced rib pain. She was seen at a physician's office. As per the consumer, "a PET scan and ultrasound showed a mass in the liver. A biopsy showed that it was not cancerous". The events were ongoing at the time of reporting to the other company on 8/19/05 and the patient had not recovered. (OMIC)
Patient administered a dose of the Moderna COVID-19 vaccine from an expired vial.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered a dose of the Moderna COVID-19 vaccine from an expired vial.) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered a dose of the Moderna COVID-19 vaccine from an expired vial.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered a dose of the Moderna COVID-19 vaccine from an expired vial.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: This report refers to a case of EXPIRED PRODUCT ADMINISTERED for mRNA-1273 (lot number unknown) with no associated AEs reported. Very limited information regarding this event has been provided at this time.
sore arm, fatigue, shortness of breath Narrative: Employee reports started with sore arm 2-3 days after the vaccine. Employee noticed fatigue 10-12 days and shortness of breath. She reports this resolved without any intervention or medical office visit.
This spontaneous report as received from a certified medical assistant refers to a multiple unspecified patients of unknown demographics. On 29-SEP-2016, the patients were vaccinated with an improperly stored doses of GARDASIL 9 lot # M009378 and expiration date: 23-APR-2018, (strength, dosage and route unspecified). The vaccine was exposed to temperature of 34.6F for the timeframe of 7 hours. The call was because of a data logger. No previous temperature excursion involved. No adverse effect reported. No product quality complaint involved. No further details provided. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from a other health professional refers to a patient of unknown age. On 28-AUG-2017 the patient was vaccinated with ZOSTAVAX lot # M042503, .65 ml, subcutaneous for prophylaxis. Concomitant therapies included sterile diluent. On 28-AUG-2017, 1 day after onset of therapy the patient experienced expired product administered. On an unknown date the patient experienced no adverse event. The outcome of expired product administered and no adverse event is unknown. The reporter considered expired product administered and no adverse event to be not related to ZOSTAVAX. Additional information has been requested.
Approximately within week after receiving MMR, client complained of chills and headaches lasting 3 days. No fever. On 7/20/04 client complained of rash on face and neck with swollen glands.
0922 pt c/ of feeling "funny"  said her mouth felt a little puffy on the left side.  Had been in Obs for 12 minutes already.  Stated she had taken her morning Phentermine but had not eaten. Transfered to the  stretcher easily.    0926 c/o of feeling increasing toungue thickness, BP 1305/78 and HR 136.  Becoming anxious and o2 sat at 100%.  Given Benedryl 50 mg po X 1.   0928.  c/o continued  more anxious.  BP no chanhe, HR >130.  Offered reassurance and stayed with pt.   0930 Pt quickly said I am having pain in my chest and sat bolt upright.  Confirmed having trouble berathing.  RR >24 and sat 100%.  Given Epi via pen at 0930.  EMS called 0932 122/85  aggitated, CP, Larm L jaw pain. 100% HR 130s 0937 EMS here
Ear ringing; Right ear pain; Ear fullness; Warmth; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 22Mar2021 at 10:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 16Mar2021, the patient underwent SARS-COV-2 test through nasal swab and the result was negative. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 00:00, one week after first dose of vaccination, the patient experienced ear ringing which began in right ear followed by pain, fullness and warmth which was ongoing at the time of report. The patient had to consulted with primary care doctor. The patient's ear was clean but pain and ringing seemed to be worsening as days went by. Therapeutic measures were taken as a result of the events which included treatment with unknown ear drops. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events ear ringing, right ear pain, ear fullness and warmth were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Breakthrough case admission after 4 vaccines Moderna 2/10/21 NO LOT#;  Moderna 3/3/21 NO LOT#;  Moderna 10/30/21 Lot# 039D21A;  moderna 4/1/22 Lot# 026L21B